(Q68726900)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2312667%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

title

Effects of recombinant leukocyte interferon on serum immunoglobulin concentrations and lymphocyte subpopulations in chronic hepatitis B (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2312667%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

1 reference

1 reference

H Tsuji

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2312667%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

K Murai

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2312667%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

K Akagi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2312667%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

M Fujishima

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2312667%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

publication date

1 January 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2312667%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Immunology

27 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2312667%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2312667%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2312667%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

page(s)

38-44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2312667%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00917496

27 September 2019

exact match

0 references

cites work

Pilot study of recombinant human alpha-interferon for chronic type B hepatitis

1 reference

12 December 2020

Human leukocyte interferon: production, purification to homogeneity, and initial characterization

1 reference

12 December 2020

Effects of recombinant leukocyte interferon (rIFN-alpha A) on tumour growth and immune responses in patients with metastatic melanoma

1 reference

12 December 2020

Immune effects of alpha-interferon in chronic liver disease

1 reference

12 December 2020

Spontaneous disappearance of viral replication and liver cell inflammation in HBsAg-positive chronic active hepatitis: results of a placebo vs. interferon trial

1 reference

12 December 2020

Recombinant Leukocyte A Interferon: Pharmacokinetics, Single-Dose Tolerance, and Biologic Effects in Cancer Patients

1 reference

12 December 2020

Interferon acts directly on human B lymphocytes to modulate immunoglobulin synthesis

1 reference

12 December 2020

Human leukocyte interferon produced by E. coli is biologically active

1 reference

12 December 2020

Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease

1 reference

12 December 2020

Cellular immunity and hepatitis-associated, Australia antigen liver disease

1 reference

12 December 2020

Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis

1 reference

12 December 2020

Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection

1 reference

12 December 2020

Effect of Interferon Therapy on Circulating Lymphocytes in Humans

1 reference

12 December 2020

Role of interferon in regulation of cytotoxicity by natural killer cells and macrophages

1 reference

12 December 2020

Bacteria-derived human leukocyte interferons alter in vitro humoral and cellular immune responses

1 reference

12 December 2020

Initial evaluation of human lymphoblastoid interferon in patients with advanced malignant disease

1 reference

12 December 2020

Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B Hepatitis

1 reference

12 December 2020

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

1 reference

12 December 2020

Synthesis in E. coli of a polypeptide with human leukocyte interferon activity

1 reference

12 December 2020

Clinical and Immunologic Effects of Recombinant Leukocyte A Interferon in Eight Patients With Advanced Cancer

1 reference

12 December 2020

Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection

1 reference

12 December 2020

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

1 reference

12 December 2020

Recombinant leukocyte a interferon treatment in patients with chronic hepatitis B virus infection. Pharmacokinetics, tolerance, and biologic effects

1 reference

12 December 2020

Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant Lymphoma

1 reference

12 December 2020

Recombinant human leukocyte interferon produced in bacteria has antiproliferative activity

1 reference

12 December 2020

T cell subsets in patients with acute and chronic HBV infection, primary biliary cirrhosis and alcohol induced liver disease

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00917496

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2312667%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

1 reference